Cellectar Biosciences, Inc.

DB:NV4 Voorraadrapport

Marktkapitalisatie: €67.2m

Cellectar Biosciences Dividend

Dividend criteriumcontroles 0/6

Cellectar Biosciences does not have a record of paying a dividend.

Belangrijke informatie

n/a

Dividendrendement

-61.3%

Terugkoop Rendement

Totaal aandeelhoudersrendement-61.3%
Toekomstig dividendrendementn/a
Dividendgroein/a
Volgende betaaldatum dividendn/a
Ex-dividenddatumn/a
Dividend per aandeeln/a
Uitbetalingsration/a

Recente dividendupdates

Geen updates

Recent updates

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Insufficient data to determine if NV4's dividends per share have been stable in the past.

Groeiend dividend: Insufficient data to determine if NV4's dividend payments have been increasing.


Dividendrendement versus markt

Cellectar Biosciences Dividendrendement versus markt
Hoe verhoudt NV4 dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (NV4)n/a
Markt onderkant 25% (DE)1.6%
Markt Top 25% (DE)4.8%
Gemiddelde industrie (Biotechs)1.5%
Analist prognose (NV4) (tot 3 jaar)n/a

Opmerkelijk dividend: Unable to evaluate NV4's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Hoog dividend: Unable to evaluate NV4's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Winstuitkering aan aandeelhouders

Verdiendekking: Insufficient data to calculate NV4's payout ratio to determine if its dividend payments are covered by earnings.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Unable to calculate sustainability of dividends as NV4 has not reported any payouts.


Ontdek bedrijven met een sterk dividend